Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangfuxin for Postoperative Pharyngeal Ulcer Pain and Wound Healing
ChiCTR2000040423Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 4 trial of kangfuxin in chronic tonsillitis, Tonsillar hyperplasia, adenoidal hypertrophy and 1 more (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Pain feeling. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
kangfuxin
03
Conditions
chronic tonsillitisTonsillar hyperplasiaadenoidal hypertrophyBenign pharyngeal tumor
Beyond the preview
Go deeper on ChiCTR2000040423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040423.